Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - CHANGE IN WORKING CAPITAL
Change in Working Capital NVO - Novo Nordisk A/S
-12.2 B
LAST VALUE
-18.94%
2 YEAR CAGR
-29.44%
5 YEAR CAGR
-46.71%
10 YEAR CAGR